Journal Mobile Options
Table of Contents
Vol. 59, No. 1, 1999
Issue release date: July 1999

Distribution of Neutral Endopeptidase Activity along the Rat and Rabbit Nephron

Edwards R.M. · Pullen M. · Nambi P.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Neutral endopeptidase (NEP) activity was measured in various nephron segments dissected from rat and rabbit kidney. In the rat, only the proximal straight tubule and glomerulus had measurable NEP activity of 86 ± 11.3 pmol/min/mm tubule length and 5.8 ± 1.5 pmol/min/glomerulus, respectively. In the rabbit, significant activity was observed in both the proximal convoluted tubule (70.8 ± 7.2 pmol/min/mm) and proximal straight tubule (29.6 ± 2.3 pmol/min/mm) as well as in the glomerulus (12.8 ± 2.2 pmol/min/glomerulus). In the rat proximal tubule, phosphoramidon and thiorphan inhibited NEP activity, with IC50 values of 26.6 ± 6.0 and 6.9 ± 1.6 nmol/l, respectively. Incubation of rat proximal tubules with phorbol 12-myristate 13-acetate resulted in a 50% reduction in membrane-associated NEP activity. The results demonstrate that in both the rat and rabbit NEP is restricted to the glomerulus and proximal tubule. This localized distribution of NEP and its potential regulation by the protein kinase C pathway may play a key role in determining local concentrations of important regulatory peptides in the kidney.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Erdos EG, Skidgel RA: Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J 1989;3:145–151.
  2. Roques BP, Noble F, Dauge V, Fournie-Zaluski M-C, Beamont A: Neutral endopeptidase 24.11: Structure, inhibition and experimental and clinical pharmacology. Pharmacol Rev 1993;45:87–146.
  3. Kenny AJ, Stephenson SL: Role of endopeptidase-24.11 in the inactivation of atrial natriuretic peptide. FEBS Lett 1988;232:1–8.
  4. Margulies KB, Cavero PG, Seymour AA, Delaney NG, Burnett JC: Neutral endopeptidase inhibition potentiates the renal actions of atrial natriuretic factor. Kidney Int 1990;38:67–72.
  5. Kerr MA, Kenny AJ: The purification and specificity of a neutral endopeptidase from rabbit kidney brush border. Biochem J 1974;137:477–488.
  6. Edwards RM, Stack EJ, Gellai M, Brooks DP: Inhibition of vasopressin-sensitive cAMP accumulation by α2-adrenoceptor agonists in collecting tubules is species dependent. Pharmacology 1992;44:26–32.
  7. Hersh L, Morihara K: Comparison of the substrate specificity of the mammalian neutral endopeptidase 24.11 (enkephalinase) to the bacterial neutral endopeptidase thermolysin. J Biol Chem 1986;261:6433–6437.

    External Resources

  8. Nambi P, Pullen M, Wu H-L, Prabhakar U, Hersh L, Gellai M: Downregulation of kidney neutral endopeptidase mRNA, protein and activity during acute renal failure: Possible mechanism for ischemia-induced acute renal failure in rats. Mol Cell Biochem 1998, in press.
  9. Erdos EG, Wagner B, Harbury CB, Painter RG, Skidgel RA, Fa X-G: Downregulation and inactivation of neutral endopeptidase 24.11 (enkephalinase) in human neutrophils. J Biol Chem 1989;264:14519–14523.
  10. Dussaule JC, Stefanski A, Bea ML, Ronco P, Ardaillou R: Characterization of neutral endopeptidase in vascular smooth muscle cells of rabbit renal cortex. Am J Physiol 1993;264:F45–F52.

    External Resources

  11. Ronco P, Pollard H, Galceran M, Delauche M, Schwartz JC, Verroust P: Distribution of enkephalinase (membrane metalloendopeptidase, EC 3.4.24.11) in rat organs. Detection using a monoclonal antibody. Lab Invest 1988;58:210–217.

    External Resources

  12. Kanazawa M, Johnston CI: Distribution and inhibition of neutral metalloendopeptidase (NEP) (EC 3.4.24.11), the major degradative enzyme for atrial natriuretic peptide, in the rat kidney. Clin Exp Pharmacol Physiol 1991;18:449–453.
  13. Kanazawa M, Casley DJ, Sybertz EJ, Haslanger MF, Johnston CI: Localization and characterization of neutral metalloendopeptidase (EC 3.4.24.11), the degradative enzyme for atrial natriuretic peptide, in rat kidney using a radioiodinated neutral metalloendopeptidase inhibitor. J Pharmacol Exp Ther 1992;261:1231–1237.
  14. Shima M, Seino Y, Tirikai S, Imai M: Intrarenal localization of degradation of atrial natriuretic peptide in isolated glomeruli and cortical nephron segments. Life Sci 1988;43:357–363.
  15. Metzgar RS, Borowitz MJ, Jones NH, Dowell BL: Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues. J Exp Med 1981;154:1249–1254.
  16. Erdos EG, Schulz WW, Gafford JT, Defendini R: Neutral metalloendopeptidase in human male genital tract. Lab Invest 1985;52:437–447.
  17. Tauc M, Chatelet P, Verroust A, Wandewalle P, Poujeol P, Ronco P: Characterization of monoclonal antibodies specific for rabbit renal brush border hydrolases: Application to immunohistological localization. J Histochem Cytochem 1988;36:523–532.

    External Resources

  18. Landry C, Santagata P, Bawab W, Fournie-Zaluski MC, Roques BP, Viany P, Crine P: Characterization of neutral endopeptidase 24.11 in dog glomeruli. Biochem J 1993;291:773–779.

    External Resources

  19. Albrightson CR, Pullen M, Wu H-L, Dytko G, Hersh LB, Nambi P: Thrombin-mediated down-regulation of endothelin receptors in mesangial cells coincides with the down regulation of neutral endopeptidase activity. Mol Pharmacol 1995;47:1156–1163.
  20. Tharaux PL, Stefanski A, Ledoux S, Soleilhac JM, Ardaillou R, Dussaule JC: EGF and TGF-β regulate neutral endopeptidase expression in renal vascular smooth muscle cells. Am J Physiol 1997;272:C1836–C1843.

    External Resources

  21. Werfel T, Sonntag G, Weber MH, Gotze O: Rapid increases in the membrane expression of neutral endopeptidase (CD10), aminopeptidase N (CD13), tyrosine phosphatase (CD45) and Fcγ-RIII(CD16) upon stimulation of human peripheral leukocytes with human C5a. J Immunol 1991;147:3909–3914.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50